Solute carrier organic anion transporter family member 1A2
Details
- Name
- Solute carrier organic anion transporter family member 1A2
- Synonyms
- OATP
- OATP-1
- OATP-A
- OATP1
- OATP1A2
- Organic anion-transporting polypeptide 1
- SLC21A3
- Sodium-independent organic anion transporter
- Solute carrier family 21 member 3
- Gene Name
- SLCO1A2
- Organism
- Humans
- Amino acid sequence
>lcl|BSEQ0007000|Solute carrier organic anion transporter family member 1A2 MGETEKRIETHRIRCLSKLKMFLLAITCAFVSKTLSGSYMNSMLTQIERQFNIPTSLVGF INGSFEIGNLLLIIFVSYFGTKLHRPIMIGIGCVVMGLGCFLKSLPHFLMNQYEYESTVS VSGNLSSNSFLCMENGTQILRPTQDPSECTKEVKSLMWVYVLVGNIVRGMGETPILPLGI SYIEDFAKFENSPLYIGLVETGAIIGPLIGLLLASFCANVYVDTGFVNTDDLIITPTDTR WVGAWWFGFLICAGVNVLTAIPFFFLPNTLPKEGLETNADIIKNENEDKQKEEVKKEKYG ITKDFLPFMKSLSCNPIYMLFILVSVIQFNAFVNMISFMPKYLEQQYGISSSDAIFLMGI YNLPPICIGYIIGGLIMKKFKITVKQAAHIGCWLSLLEYLLYFLSFLMTCENSSVVGINT SYEGIPQDLYVENDIFADCNVDCNCPSKIWDPVCGNNGLSYLSACLAGCETSIGTGINMV FQNCSCIQTSGNSSAVLGLCDKGPDCSLMLQYFLILSAMSSFIYSLAAIPGYMVLLRCMK SEEKSLGVGLHTFCTRVFAGIPAPIYFGALMDSTCLHWGTLKCGESGACRIYDSTTFRYI YLGLPAALRGSSFVPALIILILLRKCHLPGENASSGTELIETKVKGKENECKDIYQKSTV LKDDELKTKL
- Number of residues
- 670
- Molecular Weight
- 74144.105
- Theoretical pI
- 5.75
- GO Classification
- Functionsbile acid transmembrane transporter activity / organic anion transmembrane transporter activity / sodium-independent organic anion transmembrane transporter activityProcessesanion transmembrane transport / bile acid and bile salt transport / bile acid metabolic process / mitophagy in response to mitochondrial depolarization / organic anion transport / small molecule metabolic process / sodium-independent organic anion transport / transmembrane transportComponentsintegral component of plasma membrane / plasma membrane
- General Function
- Sodium-independent organic anion transmembrane transporter activity
- Specific Function
- Mediates the Na(+)-independent transport of organic anions such as sulfobromophthalein (BSP) and conjugated (taurocholate) and unconjugated (cholate) bile acids (By similarity). Selectively inhibited by the grapefruit juice component naringin.
- Pfam Domain Function
- Transmembrane Regions
- 21-40 60-80 87-111 156-184 204-224 243-267 312-333 354-377 382-405 514-536 546-571 606-623
- Cellular Location
- Cell membrane
- Gene sequence
>lcl|BSEQ0012532|Solute carrier organic anion transporter family member 1A2 (SLCO1A2) ATGGGAGAAACTGAGAAAAGAATTGAAACCCATAGAATAAGATGTCTTTCCAAGTTGAAG ATGTTTCTGTTGGCAATAACATGTGCATTTGTATCCAAAACACTGTCTGGATCTTATATG AATTCCATGCTCACACAAATAGAGAGACAATTCAACATCCCAACATCTCTAGTTGGATTC ATTAATGGAAGCTTTGAGATTGGAAATCTTTTGTTGATTATATTTGTGAGTTATTTTGGA ACCAAACTGCATAGACCTATAATGATTGGCATTGGATGTGTGGTTATGGGCTTAGGCTGT TTCTTAAAATCACTACCTCATTTCCTCATGAACCAATATGAATATGAATCTACAGTTTCA GTTTCAGGCAACTTGTCCTCAAACAGTTTCTTGTGTATGGAAAATGGAACCCAGATTTTA AGACCAACGCAGGATCCATCAGAGTGTACAAAGGAAGTTAAATCATTAATGTGGGTGTAC GTCCTAGTAGGCAATATTGTACGTGGAATGGGTGAAACTCCCATCCTGCCTTTGGGTATT TCCTATATAGAAGATTTTGCCAAATTTGAAAATTCTCCTTTATATATTGGGCTTGTAGAA ACAGGAGCTATTATTGGTCCTTTGATTGGACTTTTGTTGGCATCATTCTGTGCAAATGTT TATGTTGACACTGGATTTGTGAACACAGATGATCTGATCATAACTCCCACTGACACTCGT TGGGTCGGTGCATGGTGGTTTGGCTTTCTGATTTGTGCAGGAGTTAACGTGCTCACTGCC ATTCCTTTTTTCTTTTTGCCCAACACACTTCCAAAGGAAGGACTAGAGACTAATGCTGAC ATCATTAAAAATGAAAATGAAGACAAACAAAAAGAAGAGGTCAAGAAGGAAAAATATGGA ATCACTAAAGATTTTCTACCTTTCATGAAAAGTCTTTCCTGCAATCCAATTTATATGCTT TTCATACTTGTAAGTGTGATACAGTTCAATGCATTCGTTAACATGATCTCCTTCATGCCT AAATACCTAGAACAGCAATATGGAATATCATCTTCAGATGCAATCTTTCTAATGGGTATT TATAACTTACCTCCAATATGTATTGGATATATAATTGGTGGTTTAATTATGAAGAAGTTC AAGATTACTGTCAAACAAGCTGCCCACATAGGATGTTGGTTATCCTTACTTGAGTATCTT CTCTATTTTTTATCTTTTCTCATGACTTGTGAAAATTCTTCAGTTGTTGGAATAAATACC TCTTATGAAGGAATTCCACAAGATTTATATGTGGAAAATGACATCTTTGCTGATTGCAAT GTGGATTGCAACTGTCCATCTAAAATATGGGATCCTGTGTGTGGAAACAATGGCTTGTCA TATCTGTCAGCTTGTCTTGCTGGTTGTGAGACATCCATTGGAACGGGAATAAACATGGTG TTCCAAAATTGCAGCTGTATTCAAACATCAGGAAATTCATCTGCAGTTCTTGGGCTGTGC GACAAAGGACCTGACTGTTCCTTGATGCTCCAGTACTTCCTAATCTTGTCAGCGATGAGC AGTTTCATTTATTCTTTGGCTGCCATACCTGGATATATGGTTCTCTTGAGGTGTATGAAA TCTGAAGAGAAGTCCCTTGGTGTGGGATTACATACATTTTGCACAAGAGTATTTGCTGGC ATTCCTGCACCTATATATTTTGGCGCTTTAATGGATTCCACATGTTTACACTGGGGAACT TTGAAATGTGGTGAGTCAGGGGCATGCAGGATATATGATTCCACCACCTTCAGATACATC TACCTCGGATTGCCGGCAGCACTAAGAGGATCAAGCTTTGTTCCAGCCTTAATCATCTTA ATTCTTTTGAGGAAGTGTCATCTACCTGGTGAAAATGCCTCTTCAGGAACAGAGCTTATA GAGACAAAAGTCAAAGGGAAGGAAAATGAGTGCAAAGATATATACCAAAAGTCCACGGTT TTGAAAGATGATGAATTGAAAACTAAATTGTAA
- Chromosome Location
- 12
- Locus
- 12p12
- External Identifiers
Resource Link UniProtKB ID P46721 UniProtKB Entry Name SO1A2_HUMAN GenBank Protein ID 885978 GenBank Gene ID U21943 HGNC ID HGNC:10956 - General References
- Kullak-Ublick GA, Hagenbuch B, Stieger B, Schteingart CD, Hofmann AF, Wolkoff AW, Meier PJ: Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver. Gastroenterology. 1995 Oct;109(4):1274-82. [Article]
- Konig J, Cui Y, Nies AT, Keppler D: Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide. J Biol Chem. 2000 Jul 28;275(30):23161-8. [Article]
- Speek M: Antisense promoter of human L1 retrotransposon drives transcription of adjacent cellular genes. Mol Cell Biol. 2001 Mar;21(6):1973-85. [Article]
- Bailey DG, Dresser GK, Leake BF, Kim RB: Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice. Clin Pharmacol Ther. 2007 Apr;81(4):495-502. doi: 10.1038/sj.clpt.6100104. Epub 2007 Feb 14. [Article]
- Lee W, Glaeser H, Smith LH, Roberts RL, Moeckel GW, Gervasini G, Leake BF, Kim RB: Polymorphisms in human organic anion-transporting polypeptide 1A2 (OATP1A2): implications for altered drug disposition and central nervous system drug entry. J Biol Chem. 2005 Mar 11;280(10):9610-7. Epub 2005 Jan 4. [Article]
- Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE: The consensus coding sequences of human breast and colorectal cancers. Science. 2006 Oct 13;314(5797):268-74. Epub 2006 Sep 7. [Article]
Drug Relations
- Drug Relations
DrugBank ID Name Drug group Pharmacological action? Actions Details DB04348 Taurocholic acid approved, experimental unknown substrateinhibitorinducer Details DB01586 Ursodeoxycholic acid approved, investigational unknown substrateinhibitorinducer Details DB02659 Cholic Acid approved unknown substrateinhibitorinducer Details DB00669 Sumatriptan approved, investigational unknown inducer Details DB01183 Naloxone approved, vet_approved unknown inhibitor Details DB00286 Conjugated estrogens approved unknown substrateinhibitor Details DB00908 Quinidine approved, investigational unknown inhibitor Details DB01045 Rifampicin approved unknown inhibitor Details DB01234 Dexamethasone approved, investigational, vet_approved unknown inhibitor Details DB00661 Verapamil approved unknown inhibitor Details DB01232 Saquinavir approved, investigational unknown inhibitor Details DB00503 Ritonavir approved, investigational unknown inhibitor Details DB00220 Nelfinavir approved no inhibitor Details DB00227 Lovastatin approved, investigational unknown inhibitor Details DB00224 Indinavir approved unknown inhibitor Details DB01032 Probenecid approved, investigational unknown inhibitor Details DB01124 Tolbutamide approved, investigational unknown inhibitor Details DB00468 Quinine approved unknown inhibitor Details DB00788 Naproxen approved, vet_approved unknown inhibitor Details DB01009 Ketoprofen approved, vet_approved unknown inhibitor Details DB00328 Indomethacin approved, investigational unknown substrateinhibitor Details DB01050 Ibuprofen approved unknown inhibitor Details DB01016 Glyburide approved unknown inhibitor Details DB02123 Glycochenodeoxycholic Acid experimental unknown substrateinhibitor Details DB03619 Deoxycholic acid approved unknown substrateinhibitor Details DB00421 Spironolactone approved unknown inhibitor Details DB00741 Hydrocortisone approved, vet_approved unknown inhibitor Details DB04630 Aldosterone experimental, investigational unknown inhibitor Details DB00655 Estrone approved unknown inhibitor Details DB04573 Estriol approved, investigational, vet_approved unknown inhibitor Details DB00635 Prednisone approved, vet_approved unknown inhibitor Details DB00860 Prednisolone approved, vet_approved unknown inhibitor Details DB01396 Digitoxin approved, investigational unknown inhibitor Details DB01092 Ouabain approved unknown substrateinhibitor Details DB00641 Simvastatin approved unknown inhibitor Details DB00175 Pravastatin approved no substrate Details DB01076 Atorvastatin approved no substrate Details DB00584 Enalapril approved, vet_approved unknown substrate Details DB00917 Dinoprostone approved unknown substrate Details DB00279 Liothyronine approved, vet_approved unknown substrate Details DB00950 Fexofenadine approved, investigational unknown substrate Details DB00728 Rocuronium approved unknown substrate Details DB00390 Digoxin approved unknown substrate Details DB00563 Methotrexate approved unknown substrate Details DB00887 Bumetanide approved unknown substrate Details DB01583 Liotrix approved unknown substrate Details DB06710 Methyltestosterone approved unknown inhibitorinducer Details DB02691 Glycocholic acid experimental, investigational unknown Details DB05804 Prasterone sulfate investigational unknown Details DB00451 Levothyroxine approved unknown substrate Details DB00291 Chlorambucil approved unknown Details DB08833 Taurochenodeoxycholic acid experimental unknown Details DB08834 Tauroursodeoxycholic acid approved, investigational unknown substrate Details DB08836 Temocapril experimental, investigational unknown Details DB01098 Rosuvastatin approved unknown Details DB08893 Mirabegron approved unknown substrate Details DB11611 Lifitegrast approved unknown substrate Details DB11591 Bilastine approved, investigational no substrate Details DB13943 Testosterone cypionate approved unknown inhibitorinducer Details DB13944 Testosterone enanthate approved unknown inhibitorinducer Details DB13946 Testosterone undecanoate approved, investigational unknown inhibitorinducer Details DB13952 Estradiol acetate approved, investigational, vet_approved unknown inhibitor Details DB13953 Estradiol benzoate approved, investigational, vet_approved unknown inhibitor Details DB13954 Estradiol cypionate approved, investigational, vet_approved unknown inhibitor Details DB13955 Estradiol dienanthate approved, investigational, vet_approved unknown inhibitor Details DB13956 Estradiol valerate approved, investigational, vet_approved unknown inhibitor Details DB01590 Everolimus approved unknown inhibitor Details DB14538 Hydrocortisone aceponate experimental, vet_approved unknown Details DB14539 Hydrocortisone acetate approved, vet_approved unknown Details DB14540 Hydrocortisone butyrate approved, vet_approved unknown Details DB14541 Hydrocortisone cypionate approved, investigational, vet_approved unknown Details DB14542 Hydrocortisone phosphate approved, vet_approved unknown Details DB14543 Hydrocortisone probutate approved, vet_approved unknown Details DB14544 Hydrocortisone valerate approved, vet_approved unknown Details DB14641 Estriol tripropionate experimental unknown Details DB09213 Dexibuprofen approved, investigational unknown Details DB11753 Rifamycin approved, investigational no inhibitor Details DB00199 Erythromycin approved, investigational, vet_approved unknown substrateinhibitor Details DB01611 Hydroxychloroquine approved unknown inhibitor Details DB15566 Prednisolone acetate approved, vet_approved unknown inhibitor Details DB01222 Budesonide approved unknown substrate Details DB01137 Levofloxacin approved, investigational unknown substrate Details DB00977 Ethinylestradiol approved unknown inhibitor Details DB00253 Medrysone approved unknown substrate Details DB01708 Prasterone approved, investigational, nutraceutical unknown substrate Details DB14631 Prednisolone phosphate approved, vet_approved unknown inhibitor Details DB14669 Betamethasone phosphate approved, vet_approved unknown inhibitor Details DB14649 Dexamethasone acetate approved, investigational, vet_approved unknown inhibitor Details DB01380 Cortisone acetate approved, investigational unknown inhibitor Details DB08912 Dabrafenib approved, investigational no substrate Details DB00619 Imatinib approved no substrate Details